Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of endothelial dysfunction in patients with systemic lupus erythematosus: role of TNF-alpha (infliximab intervention)
2005-000499-41Phase 2Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Jun 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of infliximab in systemic lupus erythematosus (SLE), sponsored by Policlinico Gemelli. Started Jun 2007; status: terminated.
02
Drugs
infliximab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2005-000499-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000499-41.